MediPharm Labs declares its addition to HMMJ Index

MediPharm Labs Corp., a specialized, research-driven cannabis extraction business licensed under the Cannabis Act, is pl...

December 31, 2018 | Monday | News
Taisho Pharmaceutical Holdings to purchase BMS's UPSA

Bristol-Myers Squibb Company recently announced that Taisho Pharmaceutical Holdings has offered to purchase Bristol-Myer...

December 30, 2018 | Sunday | News
Prevelance of colistin-resistance high in Vietnam: Research

A team of researchers led by Osaka University examined the dissemination of colistin-resistant bacteria among residents ...

December 28, 2018 | Friday | News
Chugai obtains approval for Genomic Mutation Analysis Program

Chugai Pharma has announced today that it has obtained regulatory approval from the Ministry of Health, Labour and Welfa...

December 27, 2018 | Thursday | News
Rakuten Aspyrian closes $284 Million Series C Financing for late-stage oncology pipeline

Rakuten Aspyrian, a biotechnology company developing precision-targeted cancer therapies based on its proprietary Photoi...

December 26, 2018 | Wednesday | News
Mundipharma applies for marketing Remimazolam in Japan

Mundipharma has submitted an application to the Japanese Pharmaceuticals and Medical Devices Agency to market Remimazola...

December 21, 2018 | Friday | News
Roivant Sciences, Daiichi Sankyo enter into broad pipeline partnership

Roivant Sciences has announced that it has entered into collaboration with Daiichi Sankyo Company, Limited (hereafter, D...

December 20, 2018 | Thursday | News
Ajinomoto and XL-protein unite to develop therapeutic compounds

Ajinomoto Bio-Pharma Services is a fully integrated contract development and manufacturing organization with sites in&nb...

December 19, 2018 | Wednesday | News
Fuji Pharma Invests in Alvotech for $50M

Biopharmaceutical company Alvotech has announced that Japan-based Fuji Pharma has acquired a 4.2% stake in the business ...

December 19, 2018 | Wednesday | News
Study shows Stelara works superbly in Crohn’s disease

Following the announcement of positive results from Janssen’s Phase III open-label long-term extension study, whic...

December 18, 2018 | Tuesday | News
AIVITA Biomedical to sell skincare line in Japan

AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, has announced that the Com...

December 18, 2018 | Tuesday | News
Eisai signs pact with Eurofarma for anti-Obesity agent

Eisai Co., Ltd. has entered into an agreement to grant exclusive development and marketing rights for its anti-obesity a...

December 17, 2018 | Monday | News
Luye Pharma submits its Parkinson’s drug for clinical trial approval

Luye Pharma announced that its new investigational drug, Rotigotine Extended Release Microspheres for Injection (LY03003...

December 13, 2018 | Thursday | News
GHIT Fund to invest $4.6M for new projects on drug development

The Global Health Innovative Technology (GHIT) Fund has announced a total of 520 million yen ($4.6 million) to support f...

December 13, 2018 | Thursday | News
Eisai, Takeda and GARDP sign pact to develop novel antibiotics

The Global Antibiotic Research and Development Partnership (GARDP), Eisai Co., Ltd. and Takeda Pharmaceutical Company Li...

December 13, 2018 | Thursday | News
HitGen, Mitsubishi Tanabe Pharma ink deal to foster drug discovery

China-based HitGen announced that the company has entered into a drug discovery research collaboration with Mitsubishi T...

December 11, 2018 | Tuesday | News
Mundipharma to distribute Norspan in Japan

Mundipharma and Hisamitsu Pharmaceutical have agreed that Hisamitsu Pharmaceutical will end distribution of dermally abs...

December 11, 2018 | Tuesday | News
Cabinet approves MoU between India, Japan for Healthcare and Wellness

The Union Cabinet chaired by Prime Minister Narendra Modi today has given its ex-post facto approval on the Memoran...

December 7, 2018 | Friday | News